These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33514840)

  • 21. Whole genome microarray analysis of gene expression in subjects with fragile X syndrome.
    Bittel DC; Kibiryeva N; Butler MG
    Genet Med; 2007 Jul; 9(7):464-72. PubMed ID: 17666893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A methylation PCR method determines
    Hadd AG; Filipovic-Sadic S; Zhou L; Williams A; Latham GJ; Berry-Kravis E; Hall DA
    Clin Epigenetics; 2016; 8():130. PubMed ID: 27980694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Method for the Molecular Cytogenetic Visualization of Fragile Site FRAXA].
    Bobokova TS; Lemskaya NA; Kolesnikova IS; Yudkin DV
    Mol Biol (Mosk); 2017; 51(4):704-709. PubMed ID: 28900090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA Methylation, Mechanisms of
    Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.
    Pastori C; Peschansky VJ; Barbouth D; Mehta A; Silva JP; Wahlestedt C
    Hum Genet; 2014 Jan; 133(1):59-67. PubMed ID: 24005575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome.
    Dahl C; Grønskov K; Larsen LA; Guldberg P; Brøndum-Nielsen K
    Clin Chem; 2007 Apr; 53(4):790-3. PubMed ID: 17259243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of Martin-Bell syndrome based on an analysis of the structural-functional changes in the 5'-untranslated region of the FMR1 gene].
    Strel'nikov VV; Nemtsova MV; Chesnokova GG; Kuleshov NP; Zaletaev DV
    Mol Biol (Mosk); 1999; 33(2):330-6. PubMed ID: 10377581
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chromatin changes caused by CGG repeat expansion in fmr1 gene].
    Yudkin DV; Lemskaya NA; Grischenko IV; Dolskiy AA
    Mol Biol (Mosk); 2015; 49(2):205-11. PubMed ID: 26065250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced RNA expression of the FMR1 gene in women with low (CGGn<26) repeats.
    Wang Q; Barad DH; Darmon SK; Kushnir VA; Wu YG; Lazzaroni-Tealdi E; Zhang L; Albertini DF; Gleicher N
    PLoS One; 2018; 13(12):e0209309. PubMed ID: 30576349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AGG/CCT interruptions affect nucleosome formation and positioning of healthy-length CGG/CCG triplet repeats.
    Volle CB; Delaney S
    BMC Biochem; 2013 Nov; 14():33. PubMed ID: 24261641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CGG repeat in the FMR1 gene: size matters.
    Willemsen R; Levenga J; Oostra BA
    Clin Genet; 2011 Sep; 80(3):214-25. PubMed ID: 21651511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of FMR1 transcript and protein levels among 74 premutation carriers.
    Peprah E; He W; Allen E; Oliver T; Boyne A; Sherman SL
    J Hum Genet; 2010 Jan; 55(1):66-8. PubMed ID: 19927162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1.
    Stöger R; Kajimura TM; Brown WT; Laird CD
    Hum Mol Genet; 1997 Oct; 6(11):1791-801. PubMed ID: 9302255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
    Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
    Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
    Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
    Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.
    Lu C; Lin L; Tan H; Wu H; Sherman SL; Gao F; Jin P; Chen D
    Hum Mol Genet; 2012 Dec; 21(23):5039-47. PubMed ID: 22914733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel methylation PCR that offers standardized determination of FMR1 methylation and CGG repeat length without southern blot analysis.
    Grasso M; Boon EM; Filipovic-Sadic S; van Bunderen PA; Gennaro E; Cao R; Latham GJ; Hadd AG; Coviello DA
    J Mol Diagn; 2014 Jan; 16(1):23-31. PubMed ID: 24177047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.
    Todd PK; Oh SY; Krans A; Pandey UB; Di Prospero NA; Min KT; Taylor JP; Paulson HL
    PLoS Genet; 2010 Dec; 6(12):e1001240. PubMed ID: 21170301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
    Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
    J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small Molecules Targeting H3K9 Methylation Prevent Silencing of Reactivated
    Kumari D; Sciascia N; Usdin K
    Genes (Basel); 2020 Mar; 11(4):. PubMed ID: 32230785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.